11th Annual Biomarkers Congress 2016

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 55 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers

6 Interactive Streams:

  • Biomarkers in Drug Discovery & Development
  • Personalised Medicine, Companion Diagnostics & Patient Testing
  • Biomarker Discovery, Verification & Validation
  • Innovations In Biomarker Research
  • Biomarker: Clinical Development & Clinical Trials
  • Clinical Diagnostics, NGS & Genomic Markers

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 11th Annual Biomarkers Congress, taking place on the 25th & 26th February 2016 at the Manchester Central Convention Complex, Manchester, UK.

Attended by over 250 participants from the pharmaceutical industry, the congress offers a balance of scientific presentations and unprecedented networking opportunities. In line with the current industry trends, day one of the congress focusses on the identification of safety biomarkers for the detection of drug-induced toxicity; using biomarkers through the various stages of R&D and the translation of biomarkers from the discovery to the exploration stages. The companion diagnostics & personalised medicine stream features the latest updates in companion diagnostics developments, regulatory updates and the future of targeted therapy, precision medicine & patient self-monitoring in healthcare.

On day two of the congress, experts will cover novel biomarker discoveries in different therapeutic areas such as immune-oncology, CNS diseases, neuroscience & psychiatry. Following on from early discovery experts will discuss late stage processes such as verification and validation strategies for biomarkers development. Do not miss out on the innovation stream, featuring insightful case study presentations on novel biomarker technologies, platforms; collaborations for advancing biomarker research and exciting updates in biomarker research.

Building on the success of previous events, the Biomarkers Congress will once again be co-located with the 3rd Annual Biomarkers in Clinical Development Congress. The Biomarkers in Clinical Development Congress presents an ideal opportunity for us to look at the role of biomarkers in clinical development, clinical trials and clinical diagnostics. Industry leaders will discuss the ever increasing role of NGS & genomic markers in clinical diagnostics & decision making. Hear the latest case studies on the use of microRNA’s, CTCs and free circulating RNA & DNA as biomarkers in clinical diagnostics.

The Biomarkers Congress forms part of Oxford Global’s highly successful life science series. Upcoming events in the series include:


Sponsors 2016





Media Partners

150InternationalJournalofBiologicalMarkers200_NEW_EBR Logo blue200200CBM_banner